Wilson Disease Gene Therapy Webinar

A medical first for Wilson disease: two trials are underway to look at gene therapy as a possible new treatment option. The University of Michigan is in a unique position since it is conducting trials of both potential therapies. In this webinar - also a first for the Wilson Disease Association to host - Michigan's Dr. Fred Askari explains the similarities and differences between the two trial approaches, who may be a possible study candidate and what this could mean for the future of those diagnosed with this rare genetic liver disease.
To provide a historical perspective to the treatment of WD, this webinar begins with a portion of the documentary, "The Story of Wilson Disease." The short film is produced by Rhonda Rowland who is also a WD patient and hosts the webinar.
Polling questions that are answered by webinar participants, along with questions from participants, follow the discussion between Rhonda and Dr. Askari.
To find out more about the gene therapy trial sponsored by Vivet/Pfizer and the trial sponsored by Ultragenyx please visit www.clinicaltrials.gov and search for "Wilson Disease".